dsip - 5MG DSIP 5mg – NewBioRx

Reduces senescence-associated secretory phenotype burden: Senescent cells secrete inflammatory cytokines, chemokines, growth factors, and proteases collectively referred to as the senescence-associated secretory phenotype (SASP)

Once exposed to air or equipment, bacteria can rapidly grow, which leads to contamination and compromises the integrity of your peptide solution

This dosing regimen helps maximize its regenerative effects and ensures continuous support for tissue healing

Plain outer packaging

Examples Pioglitazone (Actos) Dosage Initial: 1530 mg once daily Maximum: 45 mg daily Rosiglitazone (Avandia) Dosage Initial: 4 mg daily as a single dose or in two divided doses Maximum: 8 mg daily as a single dose or in two divided doses Possible side effects include: Weight gain Fluid retention (edema), including macular edema Increased risk of heart failure (related to fluid retention) Osteoporosis and bone fracture Possible increased risk of bladder cancer with pioglitazone Alpha-glucosidase inhibitors Primary mechanism(s) of action Inhibition of intestinal -glucosidase and pancreatic -amylase, which reduces carbohydrate absorption